Essentially, the goal of the program is to substantially enhance quality of life by decreasing the impact of cancer on military service members, their families, and the American public.
|
The guidelines of the program requires the applicants to focus their studies on blood cancers, colorectal cancers, genetic cancer research, kidney cancer, melanoma and other skin cancers, listeria vaccine for cancer, mesothelioma, pancreatic cancer, and pediatric brain tumors.
In this regard, the program intends to offer opportunities for individuals in the early stages of their careers who are looking to obtain funding, mentoring, and necessary experience that would help them push for an independent position at the forefronts of cancer research.
The Department of the Army is set to administer funds in the amount of $3,460,000 in order to support the aforementioned initiatives.
The institutions and organizations who will be assumed eligible to submit an application under this program are the following:
a) Private Investigators
b) Independent Researchers
c) Early-career investigator
In addition, the applications from said candidates will only be accepted if they meet the following requirements:
a) Hold a position at or above the level of an Associate Professor (or equivalent); and
b) Have a proven publication and funding record in at least one of the focus topic areas; and
c) Not have a major research focus in breast, prostate, lung (excluding mesothelioma), or ovarian cancer.
Peer Reviewed Cancer Career Development Award Program
Back to Page 1
About The Author Iola Bonggay is an editor of TopGovernmentGrants.com one the the most comprehensive Websites offering information on government grants and federal government programs. She also maintains Websites providing resources on environmental grants and grants for youth programs. |
Chris Raine, an MBA student and Skoll Scholar at Saïd Business School, Oxford University who fundamentally believes in social entrepreneurship, founded an online community program called Hello Sunday Morning.